172 related articles for article (PubMed ID: 24819665)
1. Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study.
Li C; Wei R; Jones-Hall YL; Vittal R; Zhang M; Liu W
Sci Rep; 2014 May; 4():4893. PubMed ID: 24819665
[TBL] [Abstract][Full Text] [Related]
2. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.
Laus AC; de Paula FE; de Lima MA; Carlos CD; Gomes INF; de Marchi P; Valente JKN; Pioltini ABM; Miziara JE; da Silva CM; Viana LS; Scapulatempo-Neto C; Reis RM
Mol Biol Rep; 2019 Apr; 46(2):2417-2425. PubMed ID: 30783937
[TBL] [Abstract][Full Text] [Related]
3. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
[TBL] [Abstract][Full Text] [Related]
4. Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.
Meng LQ
Tumour Biol; 2014 Dec; 35(12):12497-508. PubMed ID: 25217982
[TBL] [Abstract][Full Text] [Related]
5. Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs).
Marinović S; Cigrovski Berković M; Zjačić-Rotkvić V; Kapitanović S
Cancer Genet; 2022 Aug; 266-267():44-50. PubMed ID: 35777127
[TBL] [Abstract][Full Text] [Related]
6. FOXP3 polymorphisms in interstitial lung disease among Chinese Han population: A genetic association study.
Yao J; Zhang T; Zhang L; Han K; Zhang L
Clin Respir J; 2018 Mar; 12(3):1182-1190. PubMed ID: 28508461
[TBL] [Abstract][Full Text] [Related]
7. Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Oncol Res; 2008; 17(4):167-74. PubMed ID: 18773861
[TBL] [Abstract][Full Text] [Related]
8. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
Leal LF; Laus AC; Cavagna R; de Paula FE; de Oliveira MA; Ribeiro DM; Hassan FM; Miziara JE; da Silva ECA; da Silva VD; De Marchi P; Reis RM
Thorac Cancer; 2020 Oct; 11(10):2987-2992. PubMed ID: 32881389
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
10. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
de Mello RA; Ferreira M; Costa S; Costa BM; Pires FS; Neves I; Almeida MI; Cunha J; Oliveira P; Hespanhol V; Reis RM
Tumour Biol; 2012 Oct; 33(5):1341-8. PubMed ID: 22457050
[TBL] [Abstract][Full Text] [Related]
11. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
12. Positive Association between
Li L; Chen S; Wen X; Wang Q; Lv G; Li J; Yang F; Zhang F; Li Y
Biomed Res Int; 2017; 2017():2905987. PubMed ID: 28470010
[TBL] [Abstract][Full Text] [Related]
13. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.
Wei R; Li C; Zhang M; Jones-Hall YL; Myers JL; Noth I; Liu W
Transl Res; 2014 May; 163(5):494-502. PubMed ID: 24434656
[TBL] [Abstract][Full Text] [Related]
14. Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma.
Fujimoto D; Tomii K; Otoshi T; Kawamura T; Tamai K; Takeshita J; Tanaka K; Matsumoto T; Monden K; Nagata K; Otsuka K; Nakagawa A; Hata A; Tachikawa R; Otsuka K; Hamakawa H; Katakami N; Takahashi Y; Imai Y
Lung Cancer; 2013 May; 80(2):159-64. PubMed ID: 23419507
[TBL] [Abstract][Full Text] [Related]
15. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & -191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA.
Zahoor W; Pandith AA; Nisar S; Qasim I; Surana M; Ganie FA; Manzoor U; Arif SH; Rasool SUA; Lateef A; Shah P; Bhat RA
Exp Oncol; 2023 Oct; 45(2):203-210. PubMed ID: 37824771
[TBL] [Abstract][Full Text] [Related]
16. The Association between Epidermal Growth Factor Receptor (
Bashir NA; Ragab ES; Khabour OF; Khassawneh BY; Alfaqih MA; Momani JA
Biomolecules; 2018 Jul; 8(3):. PubMed ID: 30011810
[TBL] [Abstract][Full Text] [Related]
17. Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.
Jin J; Xue L; Bai X; Zhang X; Tian Q; Xie A
Neurosci Lett; 2020 Sep; 736():135273. PubMed ID: 32712352
[TBL] [Abstract][Full Text] [Related]
18. The association of epidermal growth factor variant with oral squamous cell carcinoma.
Ertugrul B; Mohammed A; Kasarci G; Bireller S; Ulusan M; Cakmakoglu B
Environ Mol Mutagen; 2023; 64(8-9):473-479. PubMed ID: 37658772
[TBL] [Abstract][Full Text] [Related]
19. Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer.
Asadian F; Ghadyani M; Antikchi MH; Dastgheib SA; Neamatzadeh H; Sheikhpour E; Khajehnoori S; Tabei SS
J Gastrointest Cancer; 2022 Mar; 53(1):78-83. PubMed ID: 33180239
[TBL] [Abstract][Full Text] [Related]
20. Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population.
Daraei A; Salehi R; Salehi M; Emami MH; Janghorbani M; Mohamadhashem F; Tavakoli H
Med Oncol; 2012 Jun; 29(2):1044-9. PubMed ID: 21567271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
